MLYS logo

Mineralys Therapeutics (MLYS) Accounts payable

annual accounts payable:

$479.00K-$122.00K(-20.30%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual accounts payable is $479.00 thousand, with the most recent change of -$122.00 thousand (-20.30%) on December 31, 2024.
  • During the last 3 years, MLYS annual accounts payable has fallen by -$284.00 thousand (-37.22%).
  • MLYS annual accounts payable is now -74.88% below its all-time high of $1.91 million, reached on December 31, 2022.

Performance

MLYS Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

quarterly accounts payable:

$373.00K-$106.00K(-22.13%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly accounts payable is $373.00 thousand, with the most recent change of -$106.00 thousand (-22.13%) on March 31, 2025.
  • Over the past year, MLYS quarterly accounts payable has dropped by -$3.89 million (-91.25%).
  • MLYS quarterly accounts payable is now -93.31% below its all-time high of $5.57 million, reached on September 30, 2023.

Performance

MLYS quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYSbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

MLYS Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.3%-91.3%
3 y3 years-37.2%-
5 y5 years-9.4%-51.1%

MLYS Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-74.9%at low-93.3%at low
5 y5-year-74.9%at low-93.3%at low
alltimeall time-74.9%at low-93.3%at low

MLYS Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$373.00K(-22.1%)
Dec 2024
$479.00K(-20.3%)
$479.00K(-84.6%)
Sep 2024
-
$3.11M(+82.0%)
Jun 2024
-
$1.71M(-59.9%)
Mar 2024
-
$4.26M(+609.0%)
Dec 2023
$601.00K
$601.00K(-89.2%)
Sep 2023
-
$5.57M(+153.8%)
DateAnnualQuarterly
Jun 2023
-
$2.20M(-8.0%)
Mar 2023
-
$2.39M(+25.2%)
Dec 2022
$1.91M(+149.9%)
$1.91M(-25.6%)
Sep 2022
-
$2.56M(+235.9%)
Dec 2021
$763.00K(+44.2%)
-
Dec 2021
-
$763.00K
Dec 2020
$529.00K
-

FAQ

  • What is Mineralys Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual accounts payable year-on-year change?
  • What is Mineralys Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly accounts payable year-on-year change?

What is Mineralys Therapeutics annual accounts payable?

The current annual accounts payable of MLYS is $479.00K

What is the all time high annual accounts payable for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual accounts payable is $1.91M

What is Mineralys Therapeutics annual accounts payable year-on-year change?

Over the past year, MLYS annual accounts payable has changed by -$122.00K (-20.30%)

What is Mineralys Therapeutics quarterly accounts payable?

The current quarterly accounts payable of MLYS is $373.00K

What is the all time high quarterly accounts payable for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly accounts payable is $5.57M

What is Mineralys Therapeutics quarterly accounts payable year-on-year change?

Over the past year, MLYS quarterly accounts payable has changed by -$3.89M (-91.25%)
On this page